Handelen Abbott Laboratories - ABT CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.23 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Abbott Laboratories ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 101.91 |
| Open* | 101.55 |
| 1-Jaarlijkse Verandering* | -13.51% |
| Dagelijks bereik* | 101.23 - 102.77 |
| 52 wekelijks bereik | 93.25-118.23 |
| Weekgemiddelde volume (10 dagen) | 4.36M |
| Gemiddeld volume (3 maanden) | 108.64M |
| Marktkapitalisatie | 176.87B |
| P/E Ratio | 30.83 |
| Uitstaande Aandelen | 1.74B |
| Omzet | 41.51B |
| EPS | 3.30 |
| Dividend (opbrengst %) | 2.0057 |
| Beta | 0.66 |
| Volgende inkomsten datum | Jul 18, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| May 31, 2023 | 101.89 | 0.79 | 0.78% | 101.10 | 102.13 | 100.26 |
| May 30, 2023 | 101.62 | -0.32 | -0.31% | 101.94 | 102.45 | 101.29 |
| May 26, 2023 | 102.79 | 0.80 | 0.78% | 101.99 | 103.38 | 101.43 |
| May 25, 2023 | 102.04 | -0.75 | -0.73% | 102.79 | 103.24 | 101.17 |
| May 24, 2023 | 103.95 | -1.50 | -1.42% | 105.45 | 105.45 | 103.87 |
| May 23, 2023 | 105.62 | -1.41 | -1.32% | 107.03 | 107.40 | 105.35 |
| May 22, 2023 | 108.13 | 0.15 | 0.14% | 107.98 | 109.24 | 107.92 |
| May 19, 2023 | 108.81 | 0.93 | 0.86% | 107.88 | 109.88 | 107.88 |
| May 18, 2023 | 108.40 | 0.38 | 0.35% | 108.02 | 108.76 | 107.54 |
| May 17, 2023 | 108.69 | -1.06 | -0.97% | 109.75 | 109.81 | 107.72 |
| May 16, 2023 | 109.28 | 0.52 | 0.48% | 108.76 | 110.37 | 108.71 |
| May 15, 2023 | 109.72 | -0.32 | -0.29% | 110.04 | 110.82 | 109.32 |
| May 12, 2023 | 110.36 | 1.14 | 1.04% | 109.22 | 110.46 | 109.12 |
| May 11, 2023 | 109.92 | -0.15 | -0.14% | 110.07 | 110.31 | 109.16 |
| May 10, 2023 | 110.60 | 0.42 | 0.38% | 110.18 | 110.87 | 109.48 |
| May 9, 2023 | 110.17 | 0.71 | 0.65% | 109.46 | 110.95 | 109.10 |
| May 8, 2023 | 110.78 | 0.42 | 0.38% | 110.36 | 111.50 | 109.79 |
| May 5, 2023 | 111.15 | 0.45 | 0.41% | 110.70 | 111.66 | 110.70 |
| May 4, 2023 | 110.78 | 0.09 | 0.08% | 110.69 | 111.40 | 110.12 |
| May 3, 2023 | 111.61 | -0.16 | -0.14% | 111.77 | 112.83 | 110.69 |
Abbott Laboratories Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Tuesday, July 18, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q2 2023 Abbott Laboratories Earnings Release Q2 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
| Tuesday, October 17, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q3 2023 Abbott Laboratories Earnings Release Q3 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 43653 | 43075 | 34608 | 31904 | 30578 |
| Inkomsten | 43653 | 43075 | 34608 | 31904 | 30578 |
| Kosten van opbrengsten, totaal | 19083 | 18490 | 14967 | 13196 | 12691 |
| Brutowinst | 24570 | 24585 | 19641 | 18708 | 17887 |
| Totale bedrijfskosten | 35336 | 34650 | 29136 | 27435 | 27095 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 11109 | 11217 | 9676 | 9694 | 9691 |
| Onderzoek & Ontwikkeling | 2741 | 2733 | 2403 | 2408 | 2288 |
| Depreciation / Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
| Ongebruikelijke uitgaven (inkomsten) | 390 | 163 | -42 | 201 | 247 |
| Bedrijfsresultaat | 8317 | 8425 | 5472 | 4469 | 3483 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -377 | -491 | -492 | -583 | -749 |
| Overige, Netto | 366 | 277 | -12 | 191 | 139 |
| Netto inkomen voor belastingen | 8306 | 8211 | 4968 | 4077 | 2873 |
| Netto inkomen na belastingen | 6933 | 7071 | 4497 | 3601 | 2464 |
| Netto inkomen voor extra. Posten | 6933 | 7071 | 4497 | 3601 | 2464 |
| Totale buitengewone posten | 0 | -2 | 86 | -96 | |
| Netto inkomen | 6933 | 7071 | 4495 | 3687 | 2368 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 6933 | 7071 | 4497 | 3601 | 2464 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 6933 | 7071 | 4495 | 3687 | 2368 |
| Verwaterd Netto Inkomen | 6933 | 7071 | 4495 | 3687 | 2368 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1764 | 1789 | 1786 | 1781 | 1770 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 3.93027 | 3.95249 | 2.51792 | 2.0219 | 1.39209 |
| Dividends per Share - Common Stock Primary Issue | 1.88 | 1.8 | 1.44 | 1.28 | 1.12 |
| Verwaterde Genormaliseerde Winst per Aandeel | 4.11623 | 4.03095 | 2.49663 | 2.12158 | 1.51177 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 9747 | 10091 | 10410 | 11257 | 11895 |
| Inkomsten | 9747 | 10091 | 10410 | 11257 | 11895 |
| Kosten van opbrengsten, totaal | 4325 | 4593 | 4629 | 4933 | 4987 |
| Brutowinst | 5422 | 5498 | 5781 | 6324 | 6908 |
| Totale bedrijfskosten | 8238 | 8787 | 8640 | 8881 | 8983 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 2751 | 2973 | 2731 | 2757 | 2787 |
| Onderzoek & Ontwikkeling | 654 | 725 | 671 | 684 | 697 |
| Depreciation / Amortization | 491 | 496 | 498 | 507 | 512 |
| Ongebruikelijke uitgaven (inkomsten) | 17 | 0 | 111 | ||
| Bedrijfsresultaat | 1509 | 1304 | 1770 | 2376 | 2912 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -58 | -52 | -105 | -106 | -114 |
| Overige, Netto | 111 | 68 | 93 | 82 | 78 |
| Netto inkomen voor belastingen | 1562 | 1320 | 1758 | 2352 | 2876 |
| Netto inkomen na belastingen | 1318 | 1033 | 1435 | 2018 | 2447 |
| Netto inkomen voor extra. Posten | 1318 | 1033 | 1435 | 2018 | 2447 |
| Totale buitengewone posten | |||||
| Netto inkomen | 1318 | 1033 | 1435 | 2018 | 2447 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 1318 | 1033 | 1435 | 2018 | 2447 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 1318 | 1033 | 1435 | 2018 | 2447 |
| Verwaterd Netto Inkomen | 1318 | 1033 | 1435 | 2018 | 2447 |
| Verwaterd Gewogen Gemiddelde Aandelen | 1751.71 | 1752.46 | 1763.65 | 1765.46 | 1774.54 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.75241 | 0.58946 | 0.81365 | 1.14304 | 1.37895 |
| Dividends per Share - Common Stock Primary Issue | 0.51 | 0.47 | 0.47 | 0.47 | 0.47 |
| Verwaterde Genormaliseerde Winst per Aandeel | 0.76059 | 0.58946 | 0.86503 | 1.14304 | 1.37895 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 25224 | 24239 | 20441 | 15667 | 14632 |
| Geldmiddelen en kortetermijnbeleggingen | 10170 | 10249 | 7148 | 4140 | 4086 |
| Geldmiddelen & Equivalenten | 9882 | 9799 | 6838 | 3860 | 3844 |
| Korte Termijn Investeringen | 288 | 450 | 310 | 280 | 242 |
| Totale Vorderingen, Netto | 6218 | 6487 | 6414 | 5425 | 5182 |
| Accounts Receivable - Trade, Net | 6218 | 6487 | 6414 | 5425 | 5182 |
| Total Inventory | 6173 | 5157 | 5012 | 4316 | 3796 |
| Prepaid Expenses | 2663 | 2346 | 1867 | 1638 | 1445 |
| Other Current Assets, Total | 148 | 123 | |||
| Total Assets | 74438 | 75196 | 72548 | 67887 | 67173 |
| Property/Plant/Equipment, Total - Net | 10278 | 10112 | 10130 | 8972 | 7563 |
| Property/Plant/Equipment, Total - Gross | 21328 | 20517 | 19894 | 17733 | 15706 |
| Accumulated Depreciation, Total | -11050 | -10405 | -9764 | -8761 | -8143 |
| Goodwill, Net | 22799 | 23231 | 23744 | 23195 | 23254 |
| Intangibles, Net | 10454 | 12739 | 14784 | 17025 | 18942 |
| Long Term Investments | 766 | 816 | 821 | 883 | 897 |
| Other Long Term Assets, Total | 4917 | 4059 | 2628 | 2145 | 1885 |
| Total Current Liabilities | 15489 | 13105 | 11907 | 10863 | 9012 |
| Accounts Payable | 4607 | 4408 | 3946 | 3252 | 2975 |
| Accrued Expenses | 7401 | 6806 | 6581 | 5183 | 4867 |
| Notes Payable/Short Term Debt | 0 | 0 | 213 | 201 | 200 |
| Current Port. of LT Debt/Capital Leases | 2251 | 754 | 7 | 1277 | 7 |
| Other Current Liabilities, Total | 1230 | 1137 | 1160 | 950 | 963 |
| Total Liabilities | 37752 | 39394 | 39764 | 36799 | 36649 |
| Total Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
| Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
| Deferred Income Tax | 991 | 1392 | 1406 | 1546 | 2056 |
| Minority Interest | 219 | 222 | 219 | 213 | 198 |
| Other Liabilities, Total | 6531 | 7379 | 7705 | 8062 | 6024 |
| Total Equity | 36686 | 35802 | 32784 | 31088 | 30524 |
| Common Stock | 24709 | 24470 | 24145 | 23853 | 23512 |
| Retained Earnings (Accumulated Deficit) | 35257 | 31528 | 27627 | 25847 | 24560 |
| Treasury Stock - Common | -15229 | -11822 | -10042 | -10147 | -9962 |
| Unrealized Gain (Loss) | 0 | 0 | |||
| Other Equity, Total | -8051 | -8374 | -8946 | -8465 | -7586 |
| Total Liabilities & Shareholders’ Equity | 74438 | 75196 | 72548 | 67887 | 67173 |
| Total Common Shares Outstanding | 1737.8 | 1764.08 | 1771.23 | 1762.5 | 1755.62 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 24377 | 25224 | 24845 | 24956 | 23429 |
| Geldmiddelen en kortetermijnbeleggingen | 9532 | 10170 | 9907 | 9290 | 8158 |
| Geldmiddelen & Equivalenten | 9161 | 9882 | 9594 | 8937 | 7675 |
| Korte Termijn Investeringen | 371 | 288 | 313 | 353 | 483 |
| Totale Vorderingen, Netto | 6020 | 6218 | 6408 | 7199 | 7179 |
| Accounts Receivable - Trade, Net | 6020 | 6218 | 6408 | 7199 | 7179 |
| Total Inventory | 6673 | 6173 | 5734 | 5899 | 5691 |
| Prepaid Expenses | 2152 | 2663 | 2796 | 2568 | 2401 |
| Total Assets | 73794 | 74438 | 72801 | 74202 | 74007 |
| Property/Plant/Equipment, Total - Net | 9282 | 9162 | 8689 | 8818 | 8908 |
| Property/Plant/Equipment, Total - Gross | 20605 | 20212 | 19306 | 19458 | 19521 |
| Accumulated Depreciation, Total | -11323 | -11050 | -10617 | -10640 | -10613 |
| Goodwill, Net | 22927 | 22799 | 22284 | 22744 | 23179 |
| Intangibles, Net | 10006 | 10454 | 10850 | 11592 | 12225 |
| Long Term Investments | 776 | 766 | 764 | 734 | 763 |
| Other Long Term Assets, Total | 6426 | 6033 | 5369 | 5358 | 5503 |
| Total Current Liabilities | 14530 | 15489 | 13365 | 12392 | 12647 |
| Accounts Payable | 4167 | 4607 | 4133 | 4493 | 4757 |
| Accrued Expenses | 6856 | 7401 | 6901 | 6715 | 6724 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2285 | 2251 | 1117 | 5 | 4 |
| Other Current Liabilities, Total | 1222 | 1230 | 1214 | 1179 | 1162 |
| Total Liabilities | 36784 | 37752 | 37126 | 37712 | 38608 |
| Total Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
| Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
| Minority Interest | 222 | 219 | 209 | 226 | 230 |
| Other Liabilities, Total | 7417 | 7522 | 8255 | 8339 | 8645 |
| Total Equity | 37010 | 36686 | 35675 | 36490 | 35399 |
| Common Stock | 24488 | 24709 | 24560 | 24429 | 24304 |
| Retained Earnings (Accumulated Deficit) | 35868 | 35257 | 35115 | 34487 | 33295 |
| Treasury Stock - Common | -15307 | -15229 | -14555 | -13720 | -13726 |
| Other Equity, Total | -8039 | -8051 | -9445 | -8706 | -8474 |
| Total Liabilities & Shareholders’ Equity | 73794 | 74438 | 72801 | 74202 | 74007 |
| Total Common Shares Outstanding | 1738.95 | 1737.8 | 1743.57 | 1751.22 | 1750.94 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 6933 | 7071 | 4495 | 3687 | 2368 |
| Geldmiddelen uit Operationele Activiteiten | 9581 | 10533 | 7901 | 6136 | 6300 |
| Geldmiddelen uit Operationele Activiteiten | 1254 | 1491 | 1195 | 1078 | 1100 |
| Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
| Niet-Geldelijke Posten | 900 | 695 | 971 | 766 | 802 |
| Cash Taxes Paid | 1864 | 1941 | 970 | 930 | 740 |
| Contant Betaalde Rente | 563 | 544 | 549 | 677 | 845 |
| Veranderingen in het Operationeel Kapitaal | -1519 | -771 | -892 | -1331 | -148 |
| Geldmiddelen uit Investeringsactiviteiten | -1740 | -2008 | -2215 | -1815 | -1356 |
| Kapitaaluitgaven | -1777 | -1885 | -2177 | -1638 | -1394 |
| Overige Cash Flow investeringsposten, Totaal | 37 | -123 | -38 | -177 | 38 |
| Geldmiddelen uit Financieringsactiviteiten | -7636 | -5494 | -2779 | -4289 | -10391 |
| Financiering van Cash Flow Posten | 0 | -11 | 0 | 0 | |
| Total Cash Dividends Paid | -3309 | -3202 | -2560 | -2270 | -1974 |
| Uitgifte (Aflossing) van aandelen, netto | -3628 | -2044 | -158 | -420 | 33 |
| Uitgifte (Aflossing) van Schulden, Netto | -699 | -248 | -50 | -1599 | -8450 |
| Wisselkoerseffecten | -122 | -70 | 71 | -16 | -116 |
| Nettowijziging in Geldmiddelen | 83 | 2961 | 2978 | 16 | -5563 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1318 | 6933 | 5900 | 4465 | 2447 |
| Cash From Operating Activities | 1143 | 9581 | 7255 | 4475 | 2065 |
| Cash From Operating Activities | 315 | 1254 | 943 | 626 | 311 |
| Amortization | 491 | 2013 | 1517 | 1019 | 512 |
| Non-Cash Items | 281 | 900 | 570 | 447 | 305 |
| Changes in Working Capital | -1262 | -1519 | -1675 | -2082 | -1510 |
| Cash From Investing Activities | -462 | -1740 | -1108 | -624 | -360 |
| Capital Expenditures | -380 | -1777 | -1167 | -700 | -321 |
| Other Investing Cash Flow Items, Total | -82 | 37 | 59 | 76 | -39 |
| Cash From Financing Activities | -1410 | -7636 | -6179 | -4636 | -3823 |
| Total Cash Dividends Paid | -890 | -3309 | -2486 | -1660 | -832 |
| Issuance (Retirement) of Stock, Net | -478 | -3628 | -2984 | -2243 | -2248 |
| Issuance (Retirement) of Debt, Net | -42 | -699 | -709 | -733 | -743 |
| Foreign Exchange Effects | 8 | -122 | -173 | -77 | -6 |
| Net Change in Cash | -721 | 83 | -205 | -862 | -2124 |
| Financing Cash Flow Items |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.9022 | 154804032 | 140826 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0365 | 87581226 | -1284956 | 2023-03-31 | LOW |
| Capital Research Global Investors | Investment Advisor | 4.3937 | 76404889 | -380473 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2241 | 73454220 | -1157666 | 2023-03-31 | LOW |
| Capital International Investors | Investment Advisor | 3.2451 | 56430955 | 3405170 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.794 | 31196788 | 598164 | 2023-03-31 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.1973 | 20820152 | 6003997 | 2023-03-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 1.1714 | 20370034 | -3516448 | 2023-03-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9919 | 17248522 | 765489 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.8721 | 15165569 | 261719 | 2023-03-31 | LOW |
| Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 0.8674 | 15083595 | -202533 | 2023-03-31 | LOW |
| BofA Global Research (US) | Research Firm | 0.821 | 14276700 | 229604 | 2023-03-31 | LOW |
| Polen Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8194 | 14249447 | -369295 | 2023-03-31 | LOW |
| State Farm Insurance Companies | Insurance Company | 0.7813 | 13587118 | 0 | 2023-03-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7577 | 13176421 | -145790 | 2023-03-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7087 | 12324688 | 44918 | 2023-03-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6984 | 12144038 | 54953 | 2023-03-31 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.69 | 11998117 | -283807 | 2023-03-31 | LOW |
| UBS Asset Management (Americas), Inc. | Investment Advisor | 0.6618 | 11509019 | 8668200 | 2023-03-31 | LOW |
| Nuveen LLC | Pension Fund | 0.6085 | 10582312 | 377456 | 2023-03-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group535K+
Handelaren
87K+
Actieve klanten per maand
$113M+
Maandelijks beleggingsvolume
$64M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Abbott Company profile
Over Abbott Laboratories
Abbott Laboratories houdt zich bezig met de ontdekking, ontwikkeling, vervaardiging en verkoop van een gediversifieerd assortiment van gezondheidsproducten. Het bedrijf is actief in vier segmenten: Gevestigde Farmaceutische Producten, Diagnostische Producten, Voedingsproducten, en Medische Hulpmiddelen. Het segment Gevestigde Farmaceutische Producten omvat gastro-enterologieproducten, gezondheidsproducten voor vrouwen, cardiovasculaire en metabolische producten, pijn en producten voor het centrale zenuwstelsel en ademhalingsmedicijnen en -vaccins. Het segment diagnostische producten omvat basislaboratoriumsystemen op het gebied van immunoassay, klinische chemie, hematologie en transfusiegeneeskunde; moleculaire diagnostiek polymerase chain reaction (PCR) instrumentensystemen; point of care-systemen; producten voor sneldiagnostiek lateral flow-tests, en informatica- en automatiseringsoplossingen. Het segment voedingsproducten omvat diverse vormen van zuigelingenvoeding en opvolgzuigelingenvoeding, voedingsproducten voor volwassenen en andere pediatrische voedingsproducten en andere.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Abbott Park Rd
ABBOTT PARK
ILLINOIS 60064-3500
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 535.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen